Welcome to CDC stacks | Efficacy of chloramphenicol therapy for typhoid carriers - 72912 | CDC Public Access | Public Health Reports
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Efficacy of chloramphenicol therapy for typhoid carriers
  • Published Date:
    Nov 1958
  • Source:
    Public Health Rep. 73(11):1039-1050
  • Language:
    English
Filetype[PDF-1.92 MB]


Details:
  • Supporting Files:
    No Additional Files
You May Also Like:
  1. Shigella surveillance report no. 34, November 1973
    Corporate Author:
    Center for Disease Control. Bureau of Epidemiology. Shigella Surveillance Activity.
    Published:
    November 1973
    Series:
    Shigella surveillance report ; no. 34
    DHEW publication ; no. (CDC) 74-8225
    Description:
    First and Second Quarters 1973 : For the period January-June 1973, 6,581 shigella isolations from humans were reported. This represents a decrease of 905 (12.1%) from the 7,486 isolations reported for the preceding 6 months and an increase of 269 (4....
    File Type:
    Filetype[PDF - 11.81 MB]
  2. Morbidity and mortality weekly report, Vol. 27, no. 1, January 6, 1978
    Corporate Author:
    Center for Disease Control
    Published:
    January 6, 1978
    Series:
    Morbidity and mortality weekly report ; v. 27, no. 1
    Description:
    International notes: Follow-up on multiple-antibiotic-resistant pneumococci - South Africa -- Quarantine measures -- Smallpox surveillance - worldwide -- Influenza - Taiwan, Finland, United States -- Current trends: Enforcement of a state's immunizat...
    File Type:
    Filetype[PDF - 734.63 KB]
  3. Shifts in Geographic Distribution and Antimicrobial Resistance during a Prolonged Typhoid Fever Outbreak — Bundibugyo and Kasese Districts, Uganda, 2009–2011
    Personal Author:
    Walters, Maroya Spalding; Routh, Janell; Mikoleit, Matthew; Kadivane, Samuel; Ouma, Caroline; Mubiru, Denis; Mbusa, Ben; Murangi, Amos; Ejoku, Emmanuel; Rwantangle, Absalom; Kule, Uziah; Lule, John; Garrett, Nancy; Halpin, Jessica; Maxwell, Nikki; Kagirita, Atek; Mulabya, Fred; Makumbi, Issa; Freeman, Molly; Joyce, Kevin; Hill, Vince; Downing, Robert; Mintz, Eric;
    Published:
    Mar 06 2014
    Source:
    PLoS Negl Trop Dis. 2014; 8(3).
    Description:
    Background : Salmonella enterica serovar Typhi is transmitted by fecally contaminated food and water and causes approximately 22 million typhoid fever infections worldwide each year. Most cases occur in developing countries, where approximately 4% of...
    File Type:
    Filetype[PDF - 424.53 KB]
  4. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
    Personal Author:
    Threlfall, E. J.; Ward, L. R.;
    Published:
    2001 May-Jun
    Source:
    Emerg Infect Dis. 7(3):448-450.
    Description:
    In 1999, 23% of Salmonella enterica serotype Typhi isolates from patients in the United Kingdom exhibited decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L); more than half were also resistant to chloramphenicol, ampicillin, and trimethopr...
    File Type:
    Filetype[PDF - 44.01 KB]
  5. ACIP typhoid fever vaccine update
    Personal Author:
    Jackson, Brendan R.
    Corporate Author:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2014 June 25-26 : Atlanta, GA)
    Published:
    June 26, 2014
    Series:
    ACIP meeting Typhoid Vaccines
    File Type:
    Filetype[PDF - 400.10 KB]